Editors' Commentary: Mechanical Circulatory Support

Circulation

Volumn 108, Issue 25, 2003, Pages 3069-3070

  Willerson, James T ^a,c   Kereiakes, Dean J ^b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b The Carl & Edyth Lindner Center for Research & Education   (United States)

^c SLEH/THI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOPTIVE IMMUNOTHERAPY; ASSISTED CIRCULATION; CARDIOPULMONARY BYPASS; HEART ASSIST DEVICE; HEART FAILURE; HEMATOPOIETIC STEM CELL; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SHORT SURVEY;

FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; PATIENT SELECTION; STEM CELL TRANSPLANTATION;

EID: 0346788539     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000110161.97393.BF     Document Type: Short Survey

References (2)

1. Frazier OH, Delgado RM. Mechanical circulatory support for advanced heart failure: where does it stand in 2003? Circulation. 2003;108:3064-3068.
2. Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation. 2003;108:3059-3063.